Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency-Reference-Cited by-同舟云学术

Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency

Published:2018-01-22 Issue:2 Volume:16 Page:253-261
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Ross C.¹,Rangarajan S.²^ORCID,Karimi M.³,Toogeh G.⁴,Apte S.⁵,Lissitchkov T.⁶,Acharya S.⁷,Manco-Johnson M. J.⁸,Srivastava A.⁹,Brand B.¹⁰,Schwartz B. A.¹¹,Knaub S.¹²,Peyvandi F.¹³^ORCID

Affiliation:

1. Department of Hematology; St John's Medical College and Hospital; Bangalore India

2. Centre For Haemostasis and Thrombosis; St Thomas’ Hospital; London UK

3. Hematology Research Center; Nemazee Hospital; Shiraz University of Medical Sciences; Shiraz Iran

4. Thrombosis Hemostasis Research Center; Tehran University of Medical Sciences; Tehran Iran

5. Sahyadri Speciality Hospital; Pune Maharashtra India

6. Department of Hemorrhagic Diathesis and Anemia; Specialized Hospital for Active Treatment (SHAT) ‘Joan Pavel’; Sofia Bulgaria

7. Cohen Children's Medical Center of New York; Northwell Health; New Hyde Park NY USA

8. Hemophilia and Thrombosis Center; University of Colorado Anschutz Medical Campus; Aurora CO USA

9. Department of Haematology; Christian Medical College; Vellore India

10. Department of Haematology; University Hospital Zurich; Zurich Switzerland

11. Clinical Research and Development; Octapharma; Hoboken NJ USA

12. Research and Development Department; Octapharma; Lachen Switzerland

13. Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Luigi Villa Foundation; Department of Pathophysiology and Transplantation; Università degli Studi di Milano; Milan Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13923/fullpdf

Reference21 articles.

1. The structure and biological features of fibrinogen and fibrin;Mosesson;Ann N Y Acad Sci,2001

2. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia;Miesbach;Thromb Res,2010

3. Rare inherited disorders of fibrinogen;Acharya;Haemophilia,2008

4. Rare bleeding disorders;Peyvandi;Haemophilia,2012

5. Recessively inherited coagulation disorders;Mannucci;Blood,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare bleeding disorders: Advances in management;Haemophilia;2024-03-18

2. Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP^®/Haemocomplettan^® P);Clinical and Applied Thrombosis/Hemostasis;2024-01

3. International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders;International Journal of Laboratory Hematology;2023-11-20

4. Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate;PLOS ONE;2023-08-30

5. Implementation of a Bleeding Management Algorithm in Liver Transplantation: A Pilot Study;Transfusion Medicine and Hemotherapy;2023-08-03